12.07.2015 Views

The Clinical Guide to Supportive and Palliative Care for HIV/AIDS

The Clinical Guide to Supportive and Palliative Care for HIV/AIDS

The Clinical Guide to Supportive and Palliative Care for HIV/AIDS

SHOW MORE
SHOW LESS
  • No tags were found...

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

A <strong>Clinical</strong> <strong>Guide</strong> <strong>to</strong> <strong>Supportive</strong> <strong>and</strong> <strong>Palliative</strong> <strong>Care</strong> <strong>for</strong> <strong>HIV</strong>/<strong>AIDS</strong> • Chapter 10: Psychiatric Problemsmay cause side effects <strong>and</strong> will not hasten a clinical response. Many patients who are in recoverymay be reluctant <strong>to</strong> take antidepressants because they believe that mind-altering substancesmust be habit-<strong>for</strong>ming. <strong>The</strong> patient must be educated <strong>and</strong> supplied with in<strong>for</strong>mation aboutdepression,26 picasits treatment, <strong>and</strong> the differences between antidepressants <strong>and</strong> benzodiazepines ornarcotics.Because they can present with similar symp<strong>to</strong>ms (poor concentration, memory impairment,fatigue <strong>and</strong>/or mental slowing), depression <strong>and</strong> other mood disorders must be differentiatedfrom MCMD or HAD. Psychostimulants are well <strong>to</strong>lerated in the medically ill patient <strong>and</strong> maytreat symp<strong>to</strong>ms of both depression <strong>and</strong> cognitive impairment. As depression <strong>and</strong> cognitive impairmen<strong>to</strong>ften co-exist in advanced <strong>HIV</strong>, psychostimulants may be used alone or in conjunctionwith an antidepressant. 63 Mood may improve significantly in the hypogonadal patient (male orfemale) with correction of the underlying <strong>and</strong>rogen deficiency. 64People with <strong>HIV</strong> may be particularly sensitive <strong>to</strong> side effects of antidepressants. Starting withlow doses <strong>and</strong> anticipating side effects <strong>for</strong> the patient increases his or her ability <strong>to</strong> <strong>to</strong>lerate themedication. It is important <strong>to</strong> allow a reasonable period of time <strong>to</strong> assess effectiveness of aparticular medication <strong>and</strong> dose.Psychological support is very important in adherence <strong>to</strong> antidepressants <strong>and</strong> other medications.Some clinical suggestions in this regard are as follows:• Start low <strong>and</strong> go slowly in dosing psychiatric medications. Increase medsaccording <strong>to</strong> the half-life <strong>and</strong> time-<strong>to</strong>-reach-steady-state <strong>to</strong> avoid overshootingtherapeutic levels.• Anticipate side effects, <strong>and</strong> suggest that most of the time they maysubside in time.• Encourage patient <strong>to</strong> call health care provider four <strong>to</strong> five days after startingmedication <strong>to</strong> report how well it is being <strong>to</strong>lerated, <strong>and</strong> what side effectsare present.• Dose sedating antidepressants one <strong>to</strong> two hours be<strong>for</strong>e sleep time <strong>to</strong> helpinitiate sleep. Taking medications right at bedtime does not give them time<strong>to</strong> be absorbed <strong>and</strong> <strong>to</strong> reach peak sedating levels.Treatment <strong>for</strong> mood disorders in children <strong>and</strong> adolescents also includes psychotropic medications<strong>and</strong> a variety of psychological <strong>and</strong> psychosocial interventions. Medications <strong>for</strong> mood disordersin children <strong>and</strong> adolescents with <strong>HIV</strong> have not been well studied, although the SSRIs areused clinically. Individual, group <strong>and</strong> family therapy are effective in treating issues specific <strong>to</strong><strong>HIV</strong> in adolescents, such as future goals, intimacy issues <strong>and</strong> self esteem. In the later stages ofdisease, preparation <strong>for</strong> disability <strong>and</strong> death may require intensive, multidisciplinary approaches.Suicide EvaluationSuicidal ideation must always be taken seriously. Table 10-20 contains important elements inevaluating suicide risk. Attempts increase under the influence of psychoactive substances <strong>and</strong>alcohol <strong>and</strong> in the midst of a delirium or psychosis. 65230U.S. Department of Health <strong>and</strong> Human Services • Health Resources <strong>and</strong> Services Administration • <strong>HIV</strong>/<strong>AIDS</strong> Bureau

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!